1
Clinical Trials associated with Tetravalent Recombinant Hand, Foot, and Mouth Disease Vaccine (Pichia pastoris) (Chongqing Huazhi) / Not yet recruitingPhase 1 随机、盲法、单中心、安慰剂/阳性对照,评价四价重组手足口病疫苗(毕赤酵母)的安全性、耐受性以及免疫原性的I期临床试验
[Translation] A randomized, blinded, single-center, placebo/positive-control Phase I clinical trial evaluating the safety, tolerability, and immunogenicity of a quadrivalent recombinant hand-foot-mouth disease vaccine (Pichia pastoris).
(1)评价四价重组手足口病疫苗(毕赤酵母)在研究人群中的安全性和耐受性;
(2)探索四价重组手足口病疫苗(毕赤酵母)在6月龄~13周岁人群中的免疫原性。
[Translation] (1) To evaluate the safety and tolerability of the quadrivalent recombinant hand-foot-mouth disease vaccine (Pichia pastoris) in the study population;
(2) To explore the immunogenicity of the quadrivalent recombinant hand-foot-mouth disease vaccine (Pichia pastoris) in people aged 6 months to 13 years.
100 Clinical Results associated with Tetravalent Recombinant Hand, Foot, and Mouth Disease Vaccine (Pichia pastoris) (Chongqing Huazhi)
100 Translational Medicine associated with Tetravalent Recombinant Hand, Foot, and Mouth Disease Vaccine (Pichia pastoris) (Chongqing Huazhi)
100 Patents (Medical) associated with Tetravalent Recombinant Hand, Foot, and Mouth Disease Vaccine (Pichia pastoris) (Chongqing Huazhi)
100 Deals associated with Tetravalent Recombinant Hand, Foot, and Mouth Disease Vaccine (Pichia pastoris) (Chongqing Huazhi)